INVESTOR RELATIONS

MET-TEST is a leader in providing patient-specific, data-driven technology using state-of-the-art analytical tools, trained specialists, and powerful proprietary pattern recognition software that enable healthcare organizations to optimize medication regimens and improve patient outcomes. This results in reduced hospitalizations, lower healthcare costs, and improved risk management. 

We have tested over 230,000 patients and accumulated real world data. We currently provide services to over 50 clinics in 10 states as well as participating in several clinical trial. We are a privately held corporation headquartered in Atlanta, Georgia.